Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 4
R&D Momentum
61/100
Pipeline Velocity
15/100
Trial Completion Rate
84/100
Pipeline Concentration
20/100
Pipeline Freshness
44/100
Strategic Signals
Activity
Last 14 days
Pilot Study on Shear-induced Platelet Aggregation in Acute Coronary Syndromes
Pathologies métaboliques et Infectieuses en Population générale à La Réunion : étude REUNION
Study of Cognitive and Behavioural Biases in People With Idiopathic Environmental Intolerance (IEI) Versus Healthy Controls
ANAkinra in Severe Juvenile Idiopathic Arthritis of Systemic Onset (ANAJIS)
Magnetic Resonance Spectroscopy Markers of Glioma Genomics
Bases évolutives et Fonctionnelles de la Menstruation Chez Les Femmes - 2
Etude Des Facteurs prédictifs de l'Apparition et de l'évolution de la Maladie de Parkinson
Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study
Study of Slow Prefrontal Cortex Oscillations During Social Exposure in Social Anxiety Disorder
European Cystinosis Cohort
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)